Clazosentan Amide Impurity - Request Quote
Clazosentan Amide Impurity
| SZ CAT No: | SZ-C278011 |
| CAS No | NA |
| Mol.F. | C25H24N6O7S |
| Mol.Wt. |
552.6 |
| Inv. Status |
Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Clazosentan Amide Impurity is chemically 4-(4-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-6-((5-methylpyridine)-2-sulfonamido)pyrimidin-2-yl)picolinamide. Clazosentan Amide Impurity is supplied with detailed characterization data compliant with regulatory guideline. Clazosentan Amide Impurity can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Clazosentan.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
buy high quality Clazosentan Amide Impurity
Purchase Clazosentan Amide Impurity
Clazosentan Amide Impurity suppliers
Clazosentan Amide Impurity manufacturers
Clazosentan Amide Impurity price
Order Clazosentan Amide Impurity
Enquire Clazosentan Amide Impurity
Clazosentan Amide Impurity cost
Clazosentan Amide Impurity Supplier
Clazosentan Amide Impurity Distributor
Clazosentan Amide Impurity for Method Validation
Clazosentan Reference Standard
Clazosentan Amide Impurity for ANDA Filing
Clazosentan Amide Impurity for Forced Degradation Studies
Clazosentan Amide Impurity Identification Standards
Clazosentan Amide Impurity for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


